The first global institution dedicated to preventing disease before it begins.
U.P. 2026 is the inaugural Universal Project of the Givingtide framework — and this is what it will build: the world’s first medical institution devoted entirely to prevention, integrating research, clinical care, policy innovation, and global training to permanently transform how humanity relates to disease.
IoP modelling projects an avoidance of 60 million premature deaths within the first decade of full operation — through prevention protocols, trained practitioners, and health systems embedded across the global network.
Estimated economic productivity restored by 2035 — representing working years recovered, treatment costs avoided, and human capital returned to productive life across the IoP’s operating regions.
The inaugural target of the IoP Medical School: 10,000 qualified Preemptologists seeded across every continent, anchored in high-burden settings, and equipped to lead prevention-first health systems.
The Global Challenge
The cost of treating disease too late
The architecture of global health has been built around a single premise: that medicine begins when symptoms appear. For most of human history, this was unavoidable. Today, it is unconscionable.
Every year, the world watches as preventable diseases advance unchallenged through populations that lack the clinical infrastructure, trained personnel, or institutional frameworks to intercept illness before it becomes crisis.
Prevention is not the absence of cure. It is the presence of foresight — and the institutional courage to act before the damage is done.
Eight million people die each year from conditions that could have been detected, intercepted, or eliminated had prevention been the system’s primary orientation.
Nearly five million children under the age of five die each year from preventable causes.
The Institution
The Institute of Preemptology
Research Centre
Foundational research into prevention science — from molecular biomarkers to population-level risk modelling.
Clinical Translation
Translating research into prevention protocols, screening programmes, and frontline care pathways.
Medical Education
Designing the curriculum for the world’s first Preemptology training programme.
Capital Structure
The investment architecture
Founding capitalisation for the research centre and clinical facilities.
The training engine for the first 10,000 qualified Preemptologists.
A flagship demonstration campus for prevention-first oncology.
Ensuring institutional permanence across generations.
Strategic Location
Positioned where prevention matters most
The flagship IoP complex will be established in Enugu, Nigeria — a deliberate, strategic choice that places the world’s first prevention institute at the intersection of greatest need and greatest opportunity.
Enugu offers the real-world testing conditions that sharpen and validate every protocol the Institute develops. Prevention science proven in Enugu is prevention science that works everywhere.
Primary research, clinical, and medical education complex. The institutional home of the Institute of Preemptology and the site of its inaugural prevention systems work.
Real-world testing at scale. Enugu provides the complexity needed to develop protocols that generalise globally.
Equity-centred innovation. Grounded in the Global South to ensure Preemptology is built for those who need it most.
The Invitation
Help build the institution that proves prevention can work.
Founding partners have the opportunity to shape the first global institute of prevention medicine and establish a legacy that endures long after any single generation.